QUICK TAKE
Section 781 of the November 2025 appropriations act switches on November 12, 2026. The Senate’s draft continuing resolution would hold part of it back until December 11, and the trade press is calling that a lifeline. Read the text. What gets held back is the total-THC definition and the 0.4 milligram per container cap. The prohibition on cannabinoids that cannot be naturally produced by the plant lands on November 12 regardless, and that means delta-8, delta-10, HHC, and THC-O. If you built a hemp aisle inside a vape business, you are on the wrong side of the carve-out. And the carve-out is not law yet.
On August 3 the industry got the headline it had been praying for since last November. Senate leaders had slipped a hemp provision into the stopgap funding bill. The U.S. Hemp Roundtable called it welcome news. Forbes ran the word “lifeline.” Half a dozen trade outlets wrote it up as a delay of the federal hemp ban, and a lot of shop owners with a wall of delta-8 cartridges exhaled for the first time in nine months.
They should not have. The delay is real, it is narrow, and the products it protects are not the products most vape retailers are sitting on. If you sell disposables and pods, the thing that kills your hemp inventory arrives on schedule.
What Switches On, and When
The law is not new and it is not pending. It was signed on November 12, 2025, buried inside the appropriations package that ended the government shutdown, with a one-year delay written into it. That year is nearly up.
It does two things. First, it replaces the delta-9-only measurement from the 2018 Farm Bill with a total THC standard, 0.3 percent measured after decarboxylation, which folds THCA into the math for the first time. Second, it caps finished consumer products at 0.4 milligrams of total THC per container. Not per serving. Per container. A single ten-milligram gummy is twenty-five times the limit for the entire package it came in. There is no reformulating around a number that low; there is only exiting the category.
Separately, and this is the part that matters most to anyone reading this, the law excludes cannabinoids that are synthesized outside the plant or that the plant cannot naturally produce. The U.S. Hemp Roundtable estimates the new definition pulls roughly 95 percent of existing hemp cannabinoid products outside the legal definition of hemp. Outside that definition, they are Schedule I controlled substances.
The Delay Is Narrower Than the Headlines
Here is what the Senate’s continuing resolution does, according to the bill text and the appropriations committee’s own summary. It funds the government through December 11. It holds the new hemp definition and the 0.4 milligram container cap in abeyance until that same date. It does not move the November 12 effective date at all. Section 781 still switches on that day.
What it switches on, for those four weeks, is the synthetic and non-naturally-producible cannabinoid prohibition. Only that. Which means the reprieve covers THCA flower, full-spectrum CBD, and the low-dose delta-9 seltzers and gummies that Total Wine and the grocery chains have been stocking. Those get until December 11. Delta-8 made by isomerizing CBD, HHC made by hydrogenating it, THC-O made by acetylating it: none of those get the extra month, because none of them come out of a plant.
Why Vape Retail Sits on the Wrong Side of the Line
This is not bad luck. It is the predictable result of which products the hemp boom pushed into vape shops specifically.
Nobody built a delta-8 cartridge business because the plant made delta-8 in useful quantities. It does not. The entire category exists because a chemist figured out that cheap CBD isolate could be converted into something intoxicating with acid and a solvent, and because the 2018 Farm Bill measured only delta-9. Vape shops got the converted cannabinoids because vape shops already had the hardware, the age-gated counter, and the customer. Dispensaries and liquor stores got the plant-derived low-dose products because those fit a beverage license and a grocery shelf. That commercial split is now a legal split, and the calendar treats the two halves differently.
Texas has already demonstrated how fast the ground can move underneath a shop. The state banned delta-8 and other synthetic THC analogues effective July 31, 2026, with criminal penalties attached to possession and sale. Federal relief arriving in December does nothing for a Texas retailer in August. If you have been through the state PMTA registry wave, you already know this pattern: state law reaches your shelf faster than federal policy ever does, and it does not wait for Washington to sort itself out.
The Reprieve Is a Draft, Not a Law
Before anyone builds a purchase order around December 11, understand what stage this is at. The Senate has not passed its continuing resolution. The House passed its own stopgap on July 20, funding agencies through December 4, and the House version contains no hemp provision whatsoever. For the extension to survive, the Senate has to pass its version and then persuade the House to accept a hemp rider that the House already left out once.
The opposition is not theoretical. The chief legal officers of 34 states and one territory sent a letter to congressional leadership telling them not to delay the ban. Every standalone fix has stalled. The Hemp Planting Predictability Act, which would push the date to 2028, sat in committee through July with no vote scheduled, and the Senate companion did the same. A repeal bill from Representative Nancy Mace has gone nowhere. Representative Andy Barr filed the Lawful Hemp Protection Act on July 22 to replace the ban with a taxed and regulated framework, with White House encouragement behind it, and it is a July bill in an election year. The 2026 Farm Bill passed the House without touching the ban, because the House Agriculture chairman’s position is that a farm bill governs plants and not finished goods.
So the honest read is that four weeks might happen, and it might not, and either way it does not cover converted cannabinoids. Anyone telling you the ban got delayed is compressing three different things into one word.
The Bill Is Bigger Than the SKUs
Losing the inventory is the visible cost. It is not the expensive one.
When a product falls outside the hemp definition it becomes a Schedule I controlled substance, and everything downstream of that classification changes at once. Section 280E of the tax code strips ordinary business expense deductions from any operation trafficking in a Schedule I substance, which is how licensed cannabis businesses end up with effective tax rates that look like typos. Payment processors and banks do not wait for enforcement; they act on the statute and the calendar, and vape merchants already know how quickly a processor can decide a category is no longer worth the risk. Landlords with controlled-substance clauses in the lease read the news too. So do insurers.
The comparison worth holding onto is one this industry has already lived through. Enforcement discretion is not permission. A product that nobody is currently prosecuting is not a legal product, and the gap between those two things is where businesses go to die quietly. We have made that argument about the disposable market more than once, and the hemp version is the same argument with a harder deadline and a criminal statute at the end of it.
What To Do Between Now and November
Audit by cannabinoid origin, not by product name. Sort every hemp SKU you carry into two piles: cannabinoids the plant makes on its own, and cannabinoids that came out of a conversion step. Your labels will not tell you which is which. Your suppliers can, and you should get the answer in writing, because the ones who will not answer are telling you something.
Build a sell-through plan, not a stock-up plan. Every outlet running “stock up before November” content is selling inventory that turns into contraband on a known date. Depth of inventory is the enemy here. The goal is to be near zero on converted cannabinoids by the first week of November, not to be sitting on a pallet you cannot legally move or return.
Call your processor and read your lease this month, not in October. Ask directly what happens to your account if you carry Schedule I product past November 12, and get the answer before you need it.
Watch December 11 as a maybe, and November 12 as a certainty. If the continuing resolution passes with the hemp language intact, the plant-derived side of your hemp business gets four extra weeks. Nothing gets more than that without new legislation, and there is no new legislation.
Who this warning is for: any vape retailer or vape site that let a hemp aisle grow into a meaningful share of revenue over the past six years, and who read this week’s headlines as a reason to keep ordering. You have roughly fourteen weeks, and the clock on your specific products is not the clock in the headline.
Who can relax slightly: shops whose hemp exposure is limited to isolate CBD and broad-spectrum products with no measurable THC. Those survive the new definition. The wellness end of the aisle mostly lives; the intoxicating end mostly does not.
And for anyone who has spent the last two years watching the nicotine side of this business get squeezed by registries, seizures, and applications nobody can afford: the hemp category was never the escape hatch it was sold as. It was a loophole with an expiration date, and Congress wrote the date down.
